ALPHA-MANNOSIDOSIS
Clinical trials for ALPHA-MANNOSIDOSIS explained in plain language.
Never miss a new study
Get alerted when new ALPHA-MANNOSIDOSIS trials appear
Sign up with your email to follow new studies for ALPHA-MANNOSIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell booster may help cord blood transplants reach the brain in kids with rare diseases
Disease control Recruiting nowThis early-stage study tests whether adding special cells (DUOC-01) to a standard cord blood transplant is safe for children with inherited metabolic diseases that damage the brain. About 40 participants, from 1 week to 21 years old, will receive the cells via a spinal injection.…
Matched conditions: ALPHA-MANNOSIDOSIS
Phase: PHASE1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated May 26, 2026 10:45 UTC
-
Scientists watch rare brain diseases unfold in 1,500 patients
Knowledge-focused Recruiting nowThis study follows 1,500 people with rare genetic brain disorders like MLD, Krabbe disease, and Batten disease. Researchers track thinking, movement, and language skills over time, and collect blood and MRI scans. The goal is to learn how these diseases progress, not to test a tr…
Matched conditions: ALPHA-MANNOSIDOSIS
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC